Clinical trial Recruiting at 1 site Interventional Ages 12 to 18

Peer coaching to support teens with eating disorders

Official title: Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders

Run by Icahn School of Medicine at Mount Sinai · NCT05562258 · Data updated 2026-11-12

This trial will test whether adding 12 weeks of phone-based coaching for either parents or patients alongside usual therapy helps parents feel less emotionally taxed and helps teens build recovery skills.

Quick facts

Study typeInterventional
Ages12 Years to 18 Years
SexAll
Enrollment70 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 1, 2023
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT05562258 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adolescents aged 12–18 with a DSM-5 eating disorder who are enrolled in treatment at the Mount Sinai Center of Excellence for Eating and Weight Disorders and have a parent/caregiver willing to participate and phone access.

Probably not a fit

Patients with a current or lifetime learning or developmental disorder, those at acute suicide risk, or those not enrolled in the Mount Sinai program are not expected to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 70 adolescents (ages 12–18) with DSM-5 eating disorders and one parent/caregiver each, all receiving treatment at a single eating disorders center. Participants are randomized to one of two 12-week arms: parent coaching plus patient educational materials, or patient coaching plus parent educational materials. Coaching participants can make brief (about 15-minute) calls with a designated coach outside regular therapy, while the education arm receives weekly online videos and follow-up questions; engagement with coaching calls will be tracked. Outcomes include measures of parent and patient self-efficacy, quality of life, illness-related distress/impairment, and changes in eating disorder symptoms and severity.

Why it matters

Potential benefit: If successful, adding brief coaching could reduce caregiver emotional burden and help patients strengthen skills that support recovery.

How similar studies have gone: Some peer-support and coaching approaches in mental health have shown promise, but applying a peer-coaching model specifically to adolescents with eating disorders is relatively novel and has limited prior data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 12 to 18 at entry to the study
* DSM-5 Diagnosis of an eating disorder
* Enrollment in treatment at the Center of Excellence for Eating and Weight Disorders Speak English
* Have access to a phone with WiFi or a data plan
* Parent and child/patient both willing to participate

Exclusion Criteria:

* Current or lifetime history of learning disorder or developmental disorder
* Acute suicide risk

Where it's running

  • Department of Psychiatry, Eating and Weight Disorders Program
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Tom Hildebrandt, PsyD — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Tom Hildebrandt, PsyD
  • Email: tom.hildebrandt@mssm.edu
  • Phone: 212-659-8673

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • PRP injection for female sexual function

    This trial tests whether a patient’s own PRP injection into the front vaginal wall can improve sexual function in women with sexual dysfunction.

    Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07920900

  • Dupilumab for Major Depressive Disorder

    This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.

    Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07908563

  • Parkinson’s Risk in Gaucher Disease Type 1

    This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.

    Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07886879

  • Personalized Exercise Recommendations for Chronic Pelvic Pain

    This study tests if an AI-powered, personalized exercise plan can help people with chronic pelvic pain see if tailored workouts work better than standard guidance.

    Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07810218

  • Buprenorphine vs morphine for pain control after cesarean delivery

    This study tests whether intrathecal buprenorphine provides better postcesarean pain relief than morphine for women undergoing a planned cesarean delivery.

    Recruiting Phase 4 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07786012

  • SCC Deep Brain Stimulation for Bipolar Depression in Bipolar I Patients

    A small study tests whether deep brain stimulation of the subcallosal cingulate can help people with bipolar I depression who have not improved with other treatments, while monitoring brain signals to watch for manic switches.

    Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07745374

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.